|
LEPU Medical Technology Co., Ltd. (300003.SZ) Évaluation DCF
CN | Healthcare | Medical - Devices | SHZ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ) Bundle
Vous cherchez à évaluer la valeur intrinsèque de Lepu Medical Technology (Beijing) Co., Ltd.? Notre calculatrice (30000003SZ) DCF intègre des données réelles avec des options de personnalisation complètes, vous permettant d'affiner vos prévisions et d'améliorer vos choix d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,795.5 | 8,038.7 | 10,659.7 | 10,609.4 | 7,979.9 | 8,689.2 | 9,461.6 | 10,302.6 | 11,218.3 | 12,215.5 |
| Revenue Growth, % | 0 | 3.12 | 32.61 | -0.4718 | -24.78 | 8.89 | 8.89 | 8.89 | 8.89 | 8.89 |
| EBITDA | 2,669.5 | 3,073.2 | 2,842.8 | 3,467.6 | 2,358.2 | 2,804.5 | 3,053.8 | 3,325.2 | 3,620.8 | 3,942.6 |
| EBITDA, % | 34.24 | 38.23 | 26.67 | 32.68 | 29.55 | 32.28 | 32.28 | 32.28 | 32.28 | 32.28 |
| Depreciation | 325.1 | 443.1 | 521.6 | 567.6 | 603.8 | 477.8 | 520.2 | 566.5 | 616.8 | 671.7 |
| Depreciation, % | 4.17 | 5.51 | 4.89 | 5.35 | 7.57 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 |
| EBIT | 2,344.4 | 2,630.1 | 2,321.3 | 2,900.0 | 1,754.4 | 2,326.7 | 2,533.6 | 2,758.8 | 3,004.0 | 3,271.0 |
| EBIT, % | 30.07 | 32.72 | 21.78 | 27.33 | 21.99 | 26.78 | 26.78 | 26.78 | 26.78 | 26.78 |
| Total Cash | 1,964.0 | 2,454.6 | 3,797.5 | 5,744.5 | 4,496.0 | 3,507.7 | 3,819.4 | 4,158.9 | 4,528.6 | 4,931.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2,341.8 | 2,226.7 | 1,796.6 | 2,141.3 | 1,921.1 | 2,065.5 | 2,249.1 | 2,449.0 | 2,666.6 | 2,903.7 |
| Account Receivables, % | 30.04 | 27.7 | 16.85 | 20.18 | 24.07 | 23.77 | 23.77 | 23.77 | 23.77 | 23.77 |
| Inventories | 1,004.8 | 1,423.7 | 1,938.9 | 2,266.6 | 2,289.5 | 1,717.8 | 1,870.5 | 2,036.7 | 2,217.7 | 2,414.9 |
| Inventories, % | 12.89 | 17.71 | 18.19 | 21.36 | 28.69 | 19.77 | 19.77 | 19.77 | 19.77 | 19.77 |
| Accounts Payable | 822.3 | 821.0 | 625.5 | 1,520.2 | 1,029.3 | 935.9 | 1,019.1 | 1,109.7 | 1,208.4 | 1,315.8 |
| Accounts Payable, % | 10.55 | 10.21 | 5.87 | 14.33 | 12.9 | 10.77 | 10.77 | 10.77 | 10.77 | 10.77 |
| Capital Expenditure | -563.1 | -600.1 | -984.4 | -905.2 | -844.7 | -748.0 | -814.5 | -886.9 | -965.7 | -1,051.5 |
| Capital Expenditure, % | -7.22 | -7.47 | -9.23 | -8.53 | -10.58 | -8.61 | -8.61 | -8.61 | -8.61 | -8.61 |
| Tax Rate, % | 19.06 | 19.06 | 19.06 | 19.06 | 19.06 | 19.06 | 19.06 | 19.06 | 19.06 | 19.06 |
| EBITAT | 1,960.4 | 2,151.0 | 1,859.6 | 2,447.0 | 1,420.0 | 1,911.8 | 2,081.7 | 2,266.8 | 2,468.3 | 2,687.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -802.0 | 1,688.9 | 1,116.1 | 2,331.8 | 885.5 | 1,975.6 | 1,534.4 | 1,670.8 | 1,819.3 | 1,981.0 |
| WACC, % | 5.04 | 5.03 | 5.02 | 5.05 | 5.02 | 5.03 | 5.03 | 5.03 | 5.03 | 5.03 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 7,758.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 2,021 | |||||||||
| Terminal Value | 66,606 | |||||||||
| Present Terminal Value | 52,104 | |||||||||
| Enterprise Value | 59,862 | |||||||||
| Net Debt | 192 | |||||||||
| Equity Value | 59,670 | |||||||||
| Diluted Shares Outstanding, MM | 1,858 | |||||||||
| Equity Value Per Share | 32.12 |
What You Will Receive
- Authentic Lepu Medical Data: Comprehensive financials – covering everything from revenue to EBIT – utilizing both actual and projected figures.
- Complete Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Updates: Automatic recalculations to assess the effects of changes on Lepu Medical's fair value.
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and in-depth projections.
- Efficient and Precise: Avoid the hassle of building models from the ground up while ensuring accuracy and adaptability.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Lepu Medical Technology (Beijing) Co., Ltd. (300003SZ).
- WACC Calculation Tool: A pre-structured Weighted Average Cost of Capital sheet with adjustable inputs specific to the company.
- Customizable Forecast Assumptions: Easily adjust growth projections, capital investments, and discount rates.
- Integrated Financial Ratios: Assess profitability, leverage, and efficiency ratios pertinent to Lepu Medical Technology (Beijing) Co., Ltd. (300003SZ).
- Interactive Dashboard and Charts: Visual representations that summarize key valuation metrics for efficient analysis.
How It Operates
- Download the Template: Gain immediate access to the Excel-based Lepu Medical DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional factors.
- Instant Calculations: The model automatically recalculates the intrinsic value of Lepu Medical Technology (Beijing) Co., Ltd. (300003SZ).
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial strategy.
Why Choose This Calculator for Lepu Medical Technology (300003SZ)?
- User-Friendly Interface: Crafted for both novices and seasoned users.
- Customizable Inputs: Adjust parameters easily to suit your analysis needs.
- Real-Time Insights: View immediate updates on Lepu Medical’s valuation as you change inputs.
- Preloaded Data: Includes Lepu Medical’s actual financial statistics for efficient assessments.
- Relied Upon by Experts: Preferred by investors and analysts for making well-informed choices.
Who Should Utilize This Product?
- Professional Investors: Develop comprehensive and trustworthy valuation models for portfolio assessment.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights for Lepu Medical Technology (300003SZ) to clients.
- Students and Educators: Leverage real-world data to practice and teach financial modeling techniques.
- Healthcare Technology Enthusiasts: Gain insights into how companies like Lepu Medical Technology (300003SZ) are valued in the marketplace.
Contents of the Template
- Pre-Filled DCF Model: Financial data for Lepu Medical Technology (Beijing) Co., Ltd. [300003SZ] already included for instant application.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Lepu Medical's profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions like growth rates, margins, and capital expenditures to suit your analysis.
- Financial Statements: Access annual and quarterly reports for in-depth evaluation.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.